Eli Lilly and Company (LLY) Lilly To Acquire Ajax Therapeutics To Advance Outcomes For Patients With Myelofibrosis And Polycythemia Vera

Eli Lilly and Company (NYSE: LLY) FY 2026 Other Release

Newsdesk: